PRISMAP: A European network for medical radioisotope production and research

October 1, 2021, 12:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

Energy markets strained by price spikes make the case for nuclear

September 16, 2021, 7:00AMANS Nuclear Cafe

Energy prices surged across Europe recently as markets were stricken by reduced output from wind turbines. Low supplies of natural gas had already boosted the cost of the gas–powered generation required to make up for dips in renewable energy sources. The result: a series of dire headlines, soaring prices for natural gas, and the startup of idled coal power plants.

SHINE plans new isotope production facility in the Netherlands

May 24, 2021, 7:00AMNuclear News
A rendering of the SHINE medical isotope production facility planned for construction in Veendam, the Netherlands. (Image: Shine)

SHINE Medical Technologies plans to locate its European medical isotope production facility in the Netherlands after a yearlong search and a review of more than 50 proposals from sites across Europe. The company announced on May 20 that construction at the site should begin in 2023 with commercial production starting in late 2025.

Leaked report says EU can tag nuclear investments as sustainable

March 30, 2021, 6:57AMNuclear News

Within the European Union, recognizing nuclear energy as green, sustainable, and worthy of investment depends on nuclear being added to the EU taxonomy of “sustainable investments that have been found to ‘do no significant harm’ to human health and to the environment.” The EU will issue a final taxonomy this year, and a decision to include nuclear power—which was excluded from a draft released in late 2020—could raise prospects for public and private nuclear investments both inside and outside the EU.

The decision rests with the European Commission (EC), which will take into consideration expert opinions, including those in a scientific report of the EC’s Joint Research Centre (JRC) that was requested last summer. The JRC's 387-page report, Technical assessment of nuclear energy with respect to the ‘do no significant harm’ criteria of Regulation (EU) 2020/852 (‘Taxonomy Regulation’), was leaked to the media and made available online on March 26. The report supports adding nuclear to the taxonomy.